SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...
SAN DIEGO, Sept. 22, 2025 /PRNewswire/ -- Building on its leadership in point-of-care diagnostic testing, QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a leading global provider of ...
Quidel Corporation QDEL recently confirmed the efficacy of its antigen tests concerning continued detection of COVID-19 variants, including Omicron. The company has been at the forefront of the battle ...
SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, issued the ...
"Physician office labs and urgent care centers are on the front lines of respiratory illness diagnosis. With the QUICKVUE Influenza + SARS Test, we're equipping healthcare providers with a reliable, ...
QuidelOrtho (QDEL) is expanding its QUICKVUE portfolio with the QUICKVUE Influenza + SARS Test, a CLIA-waived, 510(k)-cleared rapid, easy-to-use immunoassay designed for professional use in physician ...
(RTTNews) - Quidel Corp. (QDEL) said that its QuickVue At-Home OTC COVID-19 Test and Sofia SARS Antigen FIA are detecting the SARS-CoV-2 Omicron variant. The company said on December 22, the U.S. Food ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback